Audit Information |
12 Months Ended |
---|---|
Dec. 31, 2024 | |
Auditor [Table] | |
Auditor Name | PKF Littlejohn LLP |
Auditor Firm ID | 2814 |
Auditor Location | London, England |
Auditor Opinion [Text Block] | Opinion on the Consolidated Financial Statements We have audited the accompanying Consolidated Balance Sheet of Tiziana Life Sciences Ltd and its subsidiaries (the “Group”) as of December 31, 2024 and 2023 and the related Consolidated Statements of Operations and Comprehensive Loss, Consolidated Statements of Cash Flows and Consolidated Statements of Shareholders’ Equity for each of the three years ended December 31, 2024 and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Group as of December 31, 2024 and 2023 and the consolidated results of its operations and its cash flows for each of the three years ended December 31, 2024 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. |